


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.64%
-3.14%
-1.40%
TMO
Thermo Fisher
$572.18
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

Expands stock buyback program
TMO Price Performance
$567.6 (+0.81%)
$479.58 (+19.31%)
$475.03 (+20.45%)
$526.07 (+8.76%)
TMO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

TMO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
TMO Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
TMO Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is TMO current stock price?
What are TMO stock strengths?
What is TMO Risk Level?
What is TMO market cap and volume?
What is TMO current Stock IQ?
Should I buy TMO stock right now?
Is TMO a Strong Buy right now?
What does a 'Strong Buy' rating mean for TMO?
What does a 'Strong Sell' rating mean for TMO?
What factors influence TMO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.64%
-3.14%
-1.40%
TMO
Thermo Fisher
Current Price
$572.18
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

Expands stock buyback program

TMO Price Performance
$567.6 (+0.81%)
$479.58 (+19.31%)
$475.03 (+20.45%)
$526.07 (+8.76%)
TMO Analysts Opinion
TMO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
TMO Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
TMO Street Sentiment is bullish and have positive views on the near-term outlook
TMO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
TMO Stock IQ
TMO Latest Analysis
Morgan Stanley Analyst Is ish On Thermo Fisher Scientific Inc. (TMO). Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 13 Best Nanotechnology Stocks to Buy Now. According to The Fly on December 2 2025 Morgan Stanley analyst Kallum Titchmarsh established a price objective of $670 up from $656. He initiated coverage of Thermo Fisher Scientific Inc. (NYSE:TMO) with an Overweight rating. According to Titchmarsh the end [….]
Fri Dec 12, 2025
Citigroup Upgrades Thermo Fisher Scientific (TMO). Fintel reports that on December 11 2025 Citigroup upgraded their outlook for Thermo Fisher Scientific (NYSE:TMO) from Neutral to Buy. Analyst Price Forecast Suggests 9.04% Upside
Fri Dec 12, 2025
Ex-Dividend Reminder: DT Midstream HCA Healthcare and Thermo Fisher Scientific . Looking at the universe of stocks we cover at Dividend Channel on 12/15/25 DT Midstream Inc (Symbol: DTM) HCA Healthcare Inc (Symbol: HCA) and Thermo Fisher Scientific Inc (Symbol: TMO) will all trade ex-dividend for their respective upcoming dividends. DT Midstream Inc will
Thu Dec 11, 2025
Looking At Thermo Fisher Scientifics Recent Unusual Options Activity. Financial giants have made a conspicuous bearish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific (NYSE:) revealed 9 unusual trades.Delving into the details we found 22% of traders were ish while 55% showed bearish tendencies. Out of all the trades we spotted 2 were puts with a value of $176400 and 7 were calls valued at $558411.Based on the trading activity it appears that the sig
Thu Dec 11, 2025
Thermo Fisher upgraded at Citi on boost in pharma spending.
Thu Dec 11, 2025
Global Molecular Cytogenetics Market Set to Reach USD 1.43 Billion by 2030 | MarketsandMarkets™. Delray Beach FL Dec. 11 2025 (GLOBE NEWSWIRE) -- Emerging markets breakthrough technologies and strategic M&.A reshape competitive landscapeThe global is projected to reach USD 1.43 billion by 2030 from USD 1.02 billion in 2025 at a CAGR of 7.1% from 2025 to 2030. The surge is attributed to rapidly increasing global cancer rates growing genetic disorder prevalence and the expanding adoption of ad
Thu Dec 11, 2025
Goldman Sachs Initiates Coverage of Thermo Fisher Scientific (TMO) with Buy Recommendation. Fintel reports that on December 9 2025 Goldman Sachs initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a Buy recommendation. Analyst Price Forecast Suggests 11.10% Upside
Wed Dec 10, 2025
Keybanc Upgrades Thermo Fisher Scientific (TMO). Fintel reports that on December 8 2025 Keybanc upgraded their outlook for Thermo Fisher Scientific (NYSE:TMO) from Sector Weight to Overweight. Analyst Price Forecast Suggests 10.21% Upside
Tue Dec 9, 2025
Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening. UK-based ) to manufacture sell and distribute its CARDIO inCode-Score test.TMO is lagging behind market performance. The agreement covers the United States Europe the Middle East and the African region.CARDIO inCode-Score is a clinically validated commercially available polygenic risk score (PRS) based on DNA extracted from a simple saliva or blood sample. The extracted DNA is scored to identify an individual’.s i
Thu Dec 4, 2025
TMO Stock Benefits From New Bioprocess Design Center in Asia. Thermo Fisher expands its Bioprocess Design Centers across Asia boosting biomanufacturing speed efficiency and regional innovation.
Wed Dec 3, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.